| Excerpt | Relevance | Reference |
|---|
| " Four experiments examined whether Ibudilast, a clinically approved neuroimmune therapy, would reduce tactile allodynia and memory impairments caused by oxaliplatin in laboratory rats." | 7.85 | Ibudilast reduces oxaliplatin-induced tactile allodynia and cognitive impairments in rats. ( Cao, J; Fardell, JE; Forrest, DRL; Hutchinson, MR; Johnston, IN; Matsos, A; Si, E; Tan, M, 2017) |
| " Four experiments examined whether Ibudilast, a clinically approved neuroimmune therapy, would reduce tactile allodynia and memory impairments caused by oxaliplatin in laboratory rats." | 3.85 | Ibudilast reduces oxaliplatin-induced tactile allodynia and cognitive impairments in rats. ( Cao, J; Fardell, JE; Forrest, DRL; Hutchinson, MR; Johnston, IN; Matsos, A; Si, E; Tan, M, 2017) |